In a retrospective cohort study examining patterns of peripheral artery disease (PAD) diagnosis in United States primary care s ...

Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, today announced the appointment of ...

Explore innovative strategies for enhancing population health through quality measures, clinician collaboration, and ...

Denials, audits and delayed payments are accelerating across ASC, and leaders say payer behavior has become more aggressive, automated and less collaborative over the past year. Five ASC executives ...

New research shows diseased kidneys release toxic extracellular vesicles into the blood, damaging the heart and explaining ...

Relationships across the ASC ecosystem are under growing strain, but ASC leaders say payers are the clear pressure point. Five executives joined Becker’s to discuss how denials, shifting policies and ...

The Preeclampsia Foundation announced the recipients of its 2026 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, they awarded two grants totaling ...

Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, ...

Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.

By Dr. Priyom Bose, Ph.D. By analyzing bowel movement frequency in more than 268,000 people, researchers uncover how thiamine ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.